Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study).

Authors

  • O. M. Gavrilyuk Львівський національний медичний університет імені Данила Галицького, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2013.4.18-22

Keywords:

angiogenesis, alcoholic steatohepatitis, nonalcoholic steatohepatitis, hepatitis C virus infection

Abstract

Background. Angiogenesis together with fibrogenesis and regeneration is an important mechanism of tissue reorganization in chronic liver diseases. Objective of the study is to examine morphologic signs of angiogenesis at the stage of cirrhotic transformation in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection. Methods. 45 autopsies with diagnosed alcoholic steatohepatitis, nonalcoholic steatohepatitis and viral hepatitis C were enrolled in this study. Diagnosis of alcoholic steatohepatitis was based on the data of alcohol abuse and morphologic signs of alcoholic disease – cardiomyopathy, chronic pancreatitis, alcoholic encephalopathy and typical liver changes. Viral genesis was proved by serological study (RNA HCV) and morphologic signs of HCV (METAVIR criteria). Diagnosis of nonalcoholic steatohepatitis was verified by the features of metabolic syndrome and hepatic changes (Brunt critera). The measures of angiogenesis employed were CD34-positive cells, evaluated in the liver tissue. Marker quantification was performed by assessing the ratio of stained tissue to the total area of the liver section using image analysis. “STATISTICA FOR WINDOWS 6.0” was used to analyze the data. Differences between groups were analyzed using ANOVA analysis (LSD test). P < 0,05 was considered significant. Results. General angiogenesis index was the highest in viral hepatitis and the lowest in nonalcoholic steatohepatitis (p<0.05). The same tendency was revealed for septal indexes: in viral hepatitis the meaning was three times higher than in steatohepatitis (difference between alcoholic and nonalcoholic steatohepatitis was not statistically significant). The highest lobular angiogenesis index was revealed in nonalcoholic steatohepatitis and the lowest in viral hepatitis (p<0.05). Conclusion. In hepatitis C virus infection CD34-positive cells are seen mostly in the septal compartment and in chronic steatohepatitis (alcoholic and nonalcoholic) – in lobular one. Such findings are in accordance with pathogenetic mechanisms of the diseases and may be used for differentiation diagnosis at the stage of cirrhotic transformation.

References

  1. Schuppan D. Liver cirrhosis / D. Schuppan, N. H. Afdhal // Lancet. – 2008. – Vol. 371, № 8. – P. 838-851.
  2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(8):838-51.
  3. Williams R. Global challenges in liver disease / R. Williams // Hepatology. – 2006. – Vol. 44. – P. 521-526.
  4. Williams R. Global challenges in liver disease. Hepatology. 2006;44:521-6.
  5. Характеристика и тенденции развития эпидемического процесса гепатита С в Украине / А. Л. Гураль, В. Ф. Мариевский, Т. А. Сергеева [и др.] // Профілактична медицина. – 2011. - № 1 – С. 9-17.
  6. Hural AL, Marievskiy VF, Sergeeva TA. [Characteristic and tendency of hepatitis C epidemic process in Ukraine]. Prophylactichna medicina. 2011;1:9-17. Russian.
  7. Popper H. Ductular reaction in the liver in hepatic injury / H. Popper, G. Kent, R. Stein // J. Mt. Sinai Hosp. – 1957. – Vol. 24. – P.551-556.
  8. Popper H, Kent G, Stein R. Ductular reaction in the liver in hepatic injury. J Mt Sinai Hosp. 1957;24:551-6.
  9. Angiogenesis in chronic inflammatory liver disease / J. Medina, A. G. Arroyo, F. Sanchez-Madrid, R. Moreno-Otero // Hepatology. – 2004. – Vol. 39. – P. 1185-1195.
  10. Medina J, Arroyo AG, Sanchez-Madrid F, Moreno-Otero R. Angiogenesis in chronic inflammatory liver disease. Hepatology. 2004;39:1185-95.
  11. McCuskey R. S. The hepatic microvascular system in health and its response to toxicants / R. S. McCuskey // Anat. Rec. – 2008. – Vol. 291. – P. 661-671.
  12. McCuskey RS. The hepatic microvascular system in health and its response to toxicants. The anatomical record. 2008;291:661-71.
  13. Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration / J. A. Chen, M. Shi, J. Q. Li, C. N. Qian // Hepatol. Int. – 2010. – Vol. 4. – P. 537-547.
  14. Chen JA, Shi M, Li JQ, Qian CN. Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration. Hepatol Int. 2010;4:537-47.
  15. Carlo I. D. CD34 expression in chronic and neoplastic liver diseases / I. D. Carlo, F. Fraggetta, R. Lombardo // Panminevra med. – 2002. – Vol. 44, №4. – P. 365-367.
  16. Carlo ID, Fraggetta F, Lombardo R. CD34 expression in chronic and neoplastic liver diseases. Panminevra Med. 2002;44(4):365-7.
  17. Kukla M. Association between liver steatosis and angiogenesis in chronic hepatitis C / M. Kukla, A. Gabriel, D. Sabat // Pol. J. Pathol. – 2010. – Vol. 61, №3. – P. 154-160.
  18. Kukla M, Gabriel A, Sabat D. Association between liver steatosis and angiogenesis in chronic hepatitis C. Pol J Pathol. 2010;61(3):154-60.
  19. Bedossa P. An algorithm for grading activity in chronic hepatitis C. The French METAVIR Cooperative Study Group / P. Bedossa, T. Poynard // Hepatology. – 1996. – Vol. 24. – P. 289-293.
  20. Bedossa P, Poynard T. An algorithm for grading activity in chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1996;24:289-93.
  21. Brunt E. M. Histopathology of nonalcoholic fatty liver disease // E. M. Brunt, D. G. Tiniakos // World J. Gastroenterol. – 2010. – Vol. 16, № 42. – P. 5286-5296.
  22. Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16(42):5286-96.
  23. Dabbs D. Diagnostic Immunohistochemistry. Theranostic and genomic application : [3rd ed.] / D. Dabbs. - NY : Saunders Elsevier, 2010. – 1452 p.
  24. Dabbs D, author. Diagnostic Immunohistochemistry. Theranostic and genomic application. 3rd ed. NY: Saunders Elsevier; 2010. 1452 p.
  25. Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases / C. Paternostro, E. David, E. Novo, M. Parola // World J. Gastroenterol. – 2010. – Vol. 16, № 21. – P. 281-288.
  26. Paternostro C, David E, Novo E, Parola M. Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases World J Gastroenterol. 2010;16(21):281-8.
  27. Mazzanti R. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients / R. Mazzanti, L. Messerini, C. E. Comin // World J. Gastroenterol. – 2007. – Vol. 13, № 37. – P. 5009-5014.
  28. Mazzanti R, Messerini L, Comin CE. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients. World J Gastroenterol. 2007;13(37):5009-14.

How to Cite

Gavrilyuk, O. M. (2013). Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study). Морфологія / Morphologia / Morfologìâ, 7(4), 18–22. https://doi.org/10.26641/1997-9665.2013.4.18-22

Issue

Section

Статті